KR830007828A - 세균성 폴리펩티드를 포현함으로써 인간 인슐린 및 이의 동족체를 제조하는 방법 - Google Patents

세균성 폴리펩티드를 포현함으로써 인간 인슐린 및 이의 동족체를 제조하는 방법 Download PDF

Info

Publication number
KR830007828A
KR830007828A KR1019810005284A KR810005284A KR830007828A KR 830007828 A KR830007828 A KR 830007828A KR 1019810005284 A KR1019810005284 A KR 1019810005284A KR 810005284 A KR810005284 A KR 810005284A KR 830007828 A KR830007828 A KR 830007828A
Authority
KR
South Korea
Prior art keywords
chimeric polypeptide
proinsulin
chain
arg
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019810005284A
Other languages
English (en)
Korean (ko)
Inventor
브이 괴델 데이비드
이따구라 케이이치
지이 클레이드 데니스
Original Assignee
토마스 디 킬레이
제넨테크 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 토마스 디 킬레이, 제넨테크 인코포레이티드 filed Critical 토마스 디 킬레이
Publication of KR830007828A publication Critical patent/KR830007828A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
KR1019810005284A 1981-01-02 1981-12-31 세균성 폴리펩티드를 포현함으로써 인간 인슐린 및 이의 동족체를 제조하는 방법 Abandoned KR830007828A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22204481A 1981-01-02 1981-01-02
US222044 1994-04-04

Publications (1)

Publication Number Publication Date
KR830007828A true KR830007828A (ko) 1983-11-07

Family

ID=22830549

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810005284A Abandoned KR830007828A (ko) 1981-01-02 1981-12-31 세균성 폴리펩티드를 포현함으로써 인간 인슐린 및 이의 동족체를 제조하는 방법

Country Status (12)

Country Link
EP (1) EP0055945A3 (OSRAM)
JP (1) JPS57163352A (OSRAM)
KR (1) KR830007828A (OSRAM)
AU (1) AU7914581A (OSRAM)
DK (1) DK582481A (OSRAM)
ES (1) ES508446A0 (OSRAM)
FI (1) FI814172A7 (OSRAM)
GR (1) GR78327B (OSRAM)
IL (1) IL64634A (OSRAM)
NZ (1) NZ199391A (OSRAM)
PH (1) PH20660A (OSRAM)
ZA (1) ZA818953B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
CA1204682A (en) * 1981-06-19 1986-05-20 Saran A. Narang Adaptors, and synthesis and cloning of proinsulin genes
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
EP0090433A1 (en) * 1982-03-31 1983-10-05 Genetics Institute, Inc. Creation of DNA sequences encoding modified proinsulin precursors
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
JP2857684B2 (ja) * 1989-05-04 1999-02-17 ジェネンテク，インコーポレイテッド ヒトリラキシンの単離のための方法および組成物
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
ATE148710T1 (de) 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
AU765574B2 (en) 1998-03-31 2003-09-25 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
RU2144957C1 (ru) * 1999-02-26 2000-01-27 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pPINS07, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ ПРОИНСУЛИН ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО ПРОИНСУЛИН ЧЕЛОВЕКА
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
HUP0301640A2 (hu) * 1999-12-29 2003-08-28 Novo Nordisk A/S. Eljárás élesztőben javított fermentációs hozammal rendelkező inzulin prekurzorok és inzulin prekurzor analógok előállítására
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
DE60120372T2 (de) 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten
US6821755B2 (en) * 2000-07-27 2004-11-23 Boehringer Ingelheim International Gmbh Preparation of a recombinant protein in a prokaryotic host cell
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors
JP4992029B2 (ja) 2003-01-31 2012-08-08 エム・エス・ディー・オス・ベー・フェー 無酸素条件でのタンパク質の単離方法
JP2009508470A (ja) 2005-07-21 2009-03-05 アボット・ラボラトリーズ Ｓｏｒｆ構築物並びにポリタンパク質、プロタンパク質及びタンパク質分解による方法を含む複数の遺伝子発現
MX2008003362A (es) 2005-09-14 2008-03-25 Sanofi Aventis Deutschland Escision de precursores de insulinas mediante una variante de tripsina.
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
CN101173006B (zh) * 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
AU2008327513B2 (en) 2007-09-21 2012-05-03 Cadila Healthcare Limited GCSF fusion protein systems suitable for high expression of peptides
KR101775000B1 (ko) 2009-06-26 2017-09-04 노보 노르디스크 에이/에스 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
CN103328006A (zh) 2010-12-14 2013-09-25 诺沃—诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
WO2012080320A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
PL2739646T3 (pl) 2011-05-10 2018-05-30 Stefan Hermann Kompleksowy układ buforowy do renaturacji ludzkiej proinsuliny lub pochodnych proinsuliny
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds
KR20190036956A (ko) 2017-09-28 2019-04-05 한미약품 주식회사 지속형 단쇄 인슐린 아날로그 및 이의 결합체
EP3845240B1 (en) 2018-09-12 2024-11-06 Amphastar Nanjing Pharmaceuticals, Inc. Pro-insulin aspart structure and method for preparing insulin aspart
BR112022013009A2 (pt) 2019-12-30 2022-09-06 Gan & Lee Pharmaceuticals Co Ltd Derivados de insulina, composição farmacêutica, uso do derivado da insulina e métodos para tratar ou prevenir diabetes, para aumentar a capacidade de um derivado de insulina e para aumentar a potência de um derivado de insulina
JP2023510218A (ja) 2019-12-30 2023-03-13 ガン アンド リー ファーマスゥーティカルズ カンパニー リミテッド 長時間作用型ｇｌｐ－１化合物
US20250340610A1 (en) 2022-01-28 2025-11-06 Gan & Lee Pharmaceuticals Co., Ltd. Acylated insulin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47891B1 (en) * 1977-11-08 1984-07-11 Genentech Inc Plasmid suitable for transformation of a bacterial host to render it capable of polypeptide expression
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
GR71912B (OSRAM) * 1978-08-11 1983-08-16 Univ California
GR70279B (OSRAM) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터

Also Published As

Publication number Publication date
IL64634A (en) 1986-03-31
FI814172L (fi) 1982-07-03
ZA818953B (en) 1983-02-23
EP0055945A3 (en) 1982-09-15
EP0055945A2 (en) 1982-07-14
AU7914581A (en) 1982-07-08
GR78327B (OSRAM) 1984-09-26
JPS57163352A (en) 1982-10-07
ES8401777A1 (es) 1984-01-01
FI814172A7 (fi) 1982-07-03
NZ199391A (en) 1985-12-13
ES508446A0 (es) 1984-01-01
IL64634A0 (en) 1982-03-31
PH20660A (en) 1987-03-23
DK582481A (da) 1982-08-13

Similar Documents

Publication Publication Date Title
KR830007828A (ko) 세균성 폴리펩티드를 포현함으로써 인간 인슐린 및 이의 동족체를 제조하는 방법
US4634677A (en) Plasmid capable of expressing human growth hormone
US4898830A (en) Human growth hormone DNA
Germino et al. Rapid purification of a cloned gene product by genetic fusion and site-specific proteolysis.
US5496924A (en) Fusion protein comprising an interleukin-2 fragment ballast portion
ATE169959T1 (de) Anthrax-toxin-fusionsproteine und deren verwendungen
JPH0673469B2 (ja) トリプトファン・プロモーター−オペレーターを用いる細菌によるポリペプチドの発現
KR870005098A (ko) 융합 단백질의 제조방법
KR950000301B1 (ko) 진핵 밸러스트 부분(ballast portion)을 갖는 융합 단백질의 제조방법
JP2009183304A (ja) 組換え分子の発現に有用なｒｎａ結合タンパク質及び結合部位
EP0797671B1 (en) A process of producing extracellular proteins in bacteria
Allen et al. Production of epidermal growth factor in Escherichia coli from a synthetic gene
JPS61275222A (ja) 上皮成長因子の製造法
CA1320162C (en) Method for stabilizing heterologous protein expression and vectors for use therein
KR0168669B1 (ko) 스트렙토마이세스에서의 외래 단백질의 제조방법
AU647025B2 (en) Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification
EP0225860B1 (en) A method to export gene products to the growth medium of gram negative bacteria
KR880014102A (ko) 스트렙토마이세테스(Streptomycetes)에서 외래성 단백질을 제조하는 방법
Geli et al. Synthesis and sequence-specific proteolysis of a hybrid protein (colicin A:: growth hormone releasing factor) produced in Escherichia coli
Curry et al. Escherichia coli expression and processing of human interleukin-1β fused to signal peptides
DK172695B1 (da) DNA-afsnit af trp-operonet fra E. coli, plasmider indeholdende DNA-afsnittet, fremgangsmåde til fremstilling af en vektor i
Miller et al. Identification of a topology control domain in the tetracycline resistance protein
KR900702047A (ko) 재조합 pdgf와 그 제조방법
Lazdunski Synthesis and sequence-specific proteolysis of a hybrid protein (colicin A:: growth hormone releasing factor) produced in zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA Escherichia coli
KR890000662A (ko) 신규한 플라스미드 제조방법 및 그를 함유한 균주를 배양하여 인터루킨-2 또는 변이 인터루킨-2를 생산하는 방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19811231

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19861230

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19811231

Comment text: Patent Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19880602

Patent event code: PE09021S01D

PC1902 Submission of document of abandonment before decision of registration